Cargando…
Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides
Polymeric immunoglobulins provide first line humoral defense at mucosal surfaces to which they are specifically transported by the polymeric immunoglobulin receptor (pIgR) on mucosal and glandular epithelial cells. Previous studies from our laboratory suggested that amino acids 402–410 of the Cα3 do...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196054/ https://www.ncbi.nlm.nih.gov/pubmed/12186846 http://dx.doi.org/10.1084/jem.20020581 |
_version_ | 1782147985905287168 |
---|---|
author | White, Kendra D. Capra, J. Donald |
author_facet | White, Kendra D. Capra, J. Donald |
author_sort | White, Kendra D. |
collection | PubMed |
description | Polymeric immunoglobulins provide first line humoral defense at mucosal surfaces to which they are specifically transported by the polymeric immunoglobulin receptor (pIgR) on mucosal and glandular epithelial cells. Previous studies from our laboratory suggested that amino acids 402–410 of the Cα3 domain of dimeric IgA (dIgA) represented a potential binding site for the pIgR. Here by binding human secretory component to overlapping decapeptides of Cα3, we confirm these residues and also uncover an additional site. Furthermore, we show that the Cα3 motif appears to be sufficient to direct transport of green fluorescent protein through the pIgR-specific cellular transcytosis system. An alternative approach identified phage peptides, selected from a library by the in vitro Madin Darby Canine Kidney transcytosis assay, for pIgR-mediated transport through epithelial cells. Some transcytosis-selected peptides map to the same 402–410 pIgR-binding Cα3 site. Further in vivo studies document that at least one of these peptides is transported in a rat model measuring hepatic bile transport. In addition to identifying small peptides that are both bound and transported by the pIgR, this study provides evidence that the pIgR-mediated mucosal secretion system may represent a means of targeting small molecule therapeutics and genes to mucosal epithelial cells. |
format | Text |
id | pubmed-2196054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21960542008-04-11 Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides White, Kendra D. Capra, J. Donald J Exp Med Brief Definitive Report Polymeric immunoglobulins provide first line humoral defense at mucosal surfaces to which they are specifically transported by the polymeric immunoglobulin receptor (pIgR) on mucosal and glandular epithelial cells. Previous studies from our laboratory suggested that amino acids 402–410 of the Cα3 domain of dimeric IgA (dIgA) represented a potential binding site for the pIgR. Here by binding human secretory component to overlapping decapeptides of Cα3, we confirm these residues and also uncover an additional site. Furthermore, we show that the Cα3 motif appears to be sufficient to direct transport of green fluorescent protein through the pIgR-specific cellular transcytosis system. An alternative approach identified phage peptides, selected from a library by the in vitro Madin Darby Canine Kidney transcytosis assay, for pIgR-mediated transport through epithelial cells. Some transcytosis-selected peptides map to the same 402–410 pIgR-binding Cα3 site. Further in vivo studies document that at least one of these peptides is transported in a rat model measuring hepatic bile transport. In addition to identifying small peptides that are both bound and transported by the pIgR, this study provides evidence that the pIgR-mediated mucosal secretion system may represent a means of targeting small molecule therapeutics and genes to mucosal epithelial cells. The Rockefeller University Press 2002-08-19 /pmc/articles/PMC2196054/ /pubmed/12186846 http://dx.doi.org/10.1084/jem.20020581 Text en Copyright © 2002, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Brief Definitive Report White, Kendra D. Capra, J. Donald Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides |
title | Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides |
title_full | Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides |
title_fullStr | Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides |
title_full_unstemmed | Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides |
title_short | Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides |
title_sort | targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides |
topic | Brief Definitive Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196054/ https://www.ncbi.nlm.nih.gov/pubmed/12186846 http://dx.doi.org/10.1084/jem.20020581 |
work_keys_str_mv | AT whitekendrad targetingmucosalsitesbypolymericimmunoglobulinreceptordirectedpeptides AT caprajdonald targetingmucosalsitesbypolymericimmunoglobulinreceptordirectedpeptides |